altimmune glp-1 drug cuts heavy drinking in mid-stage trial for alcohol use disorder GSK shares rise as $2.5B

This compliance adds an extra layer of trust and reliability, ensuring that the serums ingredients and production processes meet rigorous benchmarks

Mechanisms of liver injury

A recent meta-analysis of randomized controlled trials (RCTs), including AMPLITUDE-O, examining six GLP-1 receptor agonists (lixisenatide, liraglutide, subcutaneous semaglutide, exenatide, dulaglutide, and efpeglenatide) reported a 21% reduction in a composite kidney outcome (macroalbuminuria, doubling of serum creatinine or 40% eGFR decline, RRT, or death from kidney disease), corresponding to a number needed to treat of 47 [73]

There are also a number of online pharmacies selling GLP-1s illegally